NASDAQ:INVA
Innoviva, Inc Stock News
$15.98
+0 (+0%)
At Close: May 17, 2024
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share
10:17am, Monday, 23'rd May 2022
Innoviva Inc (NASDAQ: INVA) has agreed to acquire Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) at $2.20 per share in cash. Innoviva currently owns approximately 60% of the outstanding shar
Innoviva (INVA) Surpasses Q1 Earnings and Revenue Estimates
10:45pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Innoviva (INVA) delivered earnings and revenue surprises of 5% and 76.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Bellus Health (BLU) Outperforming Other Medical Stocks This Year?
01:40pm, Monday, 25'th Apr 2022 Zacks Investment Research
Here is how Bellus Health (BLU) and Innoviva (INVA) have performed compared to their sector so far this year.
Earnings Preview: Innoviva (INVA) Q1 Earnings Expected to Decline
07:01pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Innoviva (INVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Innoviva (INVA) Q1 Earnings Expected to Decline
04:34pm, Wednesday, 20'th Apr 2022
Innoviva (INVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Johnson & Johnson (JNJ) Tops Q1 Earnings Estimates
11:45am, Tuesday, 19'th Apr 2022 Zacks Investment Research
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 2.69% and 1.37%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Reasons to Add Novo Nordisk (NVO) Stock to Your Portfolio
04:52pm, Monday, 11'th Apr 2022 Zacks Investment Research
Novo Nordisk's (NVO) portfolio of marketed drugs are driving year over year growth. The company has one of the broadest diabetes portfolios in the industry.
Pfizer (PFE) to Boost RSV Portfolio With ReViral Acquisition
04:26pm, Friday, 08'th Apr 2022 Zacks Investment Research
Pfizer (PFE) inks an agreement to acquire ReViral for up to $525 million, which will add the latter's respiratory syncytial virus therapeutic candidates to its portfolio.
Zacks.com featured highlights include Meridian Bioscience, Innoviva, OP Bancorp and United Fire Group
12:06pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Meridian Bioscience, Innoviva, OP Bancorp and United Fire Group are part of Screen of the Week article.
Novartis (NVS) Gets FDA Nod for Vijoice in Rare Disorder
03:58pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
The FDA approves Novartis' (NVS) Vijoice (alpelisib) for the treatment of select patients with PIK3CA-related overgrowth spectrum.
Bet on These 4 Low-Beta Stocks to Combat Market Volatility
12:45pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), OP Bancorp (OPBK) and United Fire Group (UFCS) are well poised to gain.
Bet on These 4 Low-Beta Stocks to Combat Market Volatility
09:47am, Wednesday, 06'th Apr 2022
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), OP Bancorp (OPBK) and United Fire Group (UFCS) are well poised to gain.
Is Innoviva (INVA) Outperforming Other Medical Stocks This Year?
01:40pm, Friday, 01'st Apr 2022 Zacks Investment Research
Here is how Innoviva (INVA) and McKesson (MCK) have performed compared to their sector so far this year.
Is Innoviva (INVA) Outperforming Other Medical Stocks This Year?
11:07am, Friday, 01'st Apr 2022
Here is how Innoviva (INVA) and McKesson (MCK) have performed compared to their sector so far this year.
J&J (JNJ) Gets FDA Nod for HIV Jab, Cabenuva, in Adolescents
04:28pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
The FDA approves Johnson & Johnson's (JNJ) Cabenuva for treating HIV-1 in virologically suppressed adolescents aged 12 years and above.
